The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...
Glutathione Tripeptide Therapy, Cellular Skin Support Mechanisms, and Telehealth Access Pathways for Injectable Peptide Options ...
A nuclear-capable missile fired into Ukraine near Poland sent a message to Europe days after its leaders agreed to postwar ...
Security teams have always known that insecure direct object references (IDORs) and broken authorization vulnerabilities exist in their codebases. Ask any ...
BridgeBio Pharma (NASDAQ:BBIO) hosted an investor webinar to outline its clinical and commercial strategy for infigratinib, ...
Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.
The 2026 pricing round will filter into retail prices across late January and February, taking inflation back up to 5%, says, ...
NASA has confirmed the upcoming milestones for its historic Artemis II mission—the first crewed flight of the Space Launch ...
Enthorin Therapeutics, LLC, a biotechnology company focused on circuit-modulating treatments for neurological and neurodevelopmental disorders, announced that its licensing partner for MRM-3379 ...
Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...
Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...
Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results